Kbc Group Nv Legend Biotech Corp Transaction History

Kbc Group Nv

$37 Billion
Q2 2025

A detailed history of Kbc Group Nv transactions in Legend Biotech Corp stock. As of the latest transaction made, Kbc Group Nv holds 17,083 shares of LEGN stock, worth $561,347. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,083

Previous 27,048 36.84%

Holding current value

$561,347

Previous $918,000 33.99%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$27.69 - $37.91 $275,930 - $377,773	-9,965 Reduced 36.84%	17,083 $606,000
Q1 2025 Apr 25, 2025	BUY	$31.43 - $39.7 $437,002 - $551,988	13,904 Added 105.78%	27,048 $918,000
Q1 2024 May 08, 2024	SELL	$55.06 - $69.99 $153,452 - $195,062	-2,787 Reduced 17.49%	13,144 $737,000
Q4 2023 Feb 13, 2024	SELL	$57.25 - $69.74 $24,045 - $29,290	-420 Reduced 2.57%	15,931 $959,000
Q3 2023 Feb 15, 2024	SELL	$63.16 - $76.5 $59,496 - $72,063	-942 Reduced 5.76%	15,409 $1.04 Million
Q2 2023 Feb 15, 2024	SELL	$46.28 - $75.01 $199,374 - $323,143	-4,308 Reduced 20.85%	16,351 $1.13 Million
Q2 2023 Jul 28, 2023	SELL	$46.28 - $75.01 $46,280 - $75,010	-1,000 Reduced 5.76%	16,351 $0
Q1 2023 Feb 14, 2024	SELL	$43.42 - $57.37 $52,104 - $68,844	-1,200 Reduced 6.47%	17,351 $837,000
Q1 2023 May 04, 2023	SELL	$43.42 - $57.37 $143,633 - $189,779	-3,308 Reduced 16.01%	17,351 $0
Q4 2022 Feb 14, 2024	SELL	$38.8 - $55.46 $132,579 - $189,506	-3,417 Reduced 15.55%	18,551 $926,000
Q3 2022 Feb 15, 2024	BUY	$38.15 - $57.1 $180,373 - $269,968	4,728 Added 29.68%	20,659 $843,000
Q3 2022 Nov 08, 2022	SELL	$38.15 - $57.1 $49,938 - $74,743	-1,309 Reduced 5.96%	20,659 $843,000
Q2 2022 Feb 14, 2024	SELL	$33.54 - $55.0 $365,485 - $599,335	-10,897 Reduced 33.16%	21,968 $1.21 Million
Q2 2022 Jul 26, 2022	SELL	$33.54 - $55.0 $365,485 - $599,335	-10,897 Reduced 33.16%	21,968 $1.21 Million
Q1 2022 Feb 14, 2024	BUY	$31.02 - $48.18 $218,225 - $338,946	7,035 Added 27.24%	32,865 $1.19 Million
Q1 2022 May 06, 2022	BUY	$31.02 - $48.18 $218,225 - $338,946	7,035 Added 27.24%	32,865 $1.19 Million
Q4 2021 Feb 14, 2024	BUY	$41.14 - $56.98 $407,244 - $564,045	9,899 Added 62.14%	25,830 $1.2 Million
Q4 2021 Feb 03, 2022	BUY	$41.14 - $56.98 $234,580 - $324,899	5,702 Added 28.33%	25,830 $1.2 Million
Q3 2021 Nov 10, 2021	SELL	$35.31 - $50.56 $251,619 - $360,290	-7,126 Reduced 26.15%	20,128 $1.02 Million
Q1 2021 Apr 26, 2021	BUY	$23.55 - $32.4 $126,816 - $174,474	5,385 Added 24.62%	27,254 $791,000
Q4 2020 Feb 10, 2021	SELL	$25.8 - $32.39 $1.17 Million - $1.47 Million	-45,297 Reduced 67.44%	21,869 $616,000
Q3 2020 Oct 28, 2020	BUY	$27.5 - $39.61 $1.85 Million - $2.66 Million	67,166 New	67,166 $2.07 Million

Others Institutions Holding LEGN

# of Institutions

238

Shares Held

59.7M

Call Options Held

591K

Put Options Held

381K

View Full List

About Legend Biotech Corp

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.5B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

More about LEGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account